Drug Co. Manager Pleads Guilty To Bextra Charges
Two months after Pfizer Inc. agreed to pay $2.3 million to settle allegations that it improperly marketed the now-defunct anti-inflammatory drug Bextra, a regional manager responsible for sales of the former...To view the full article, register now.
Already a subscriber? Click here to view full article